Viridian Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Go back to Viridian Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
(NASDAQ: VRDN) Delayed: 22.47 -0.35 (1.53%)
Previous Close $22.82    52 Week High $ 
Open $22.75    52 Week Low $ 
Day High $22.75    P/E N/A 
Day Low $21.92    EPS $ 
Volume 403,895